Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club

Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA) accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid operators' CTO registries and is an important component of CTO crossing algorithms. The Stingray device can facilitate ante...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Catheter Cardiovasc Interv
Autori principali: Wu, Eugene B., Brilakis, Emmanouil S., Lo, Sidney, Kalyanasundaram, Arun, Mashayekhi, Kambis, Kao, Hsien‐Li, Lim, Soo‐Teik, Ge, Lei, Chen, Ji‐Yan, Qian, Jie, Lee, Seung‐Whan, Harding, Scott A., Tsuchikane, Etsuo
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2019
Soggetti:
Coronary Artery Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754104/
https://ncbi.nlm.nih.gov/pubmed/31769597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.28607
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi